You've done the reading. You know finasteride blocks the enzyme that turns testosterone into DHT, and you know DHT is the hormone driving male-pattern hair loss. But before you start anything, there's a quieter question a good provider will raise first: are kids still on the table?
Why DHT matters — and why blocking it has downstream effects
Male-pattern hair loss (androgenetic alopecia) is largely driven by dihydrotestosterone, or DHT, a more potent androgen than testosterone. DHT is produced when the enzyme 5-alpha-reductase converts testosterone. Finasteride inhibits the type II form of that enzyme, which lowers scalp and serum DHT [1][2].
Here's the part the mechanism-first crowd tends to skip: 5-alpha-reductase and DHT aren't only involved in hair follicles. DHT plays a role in the development and function of male reproductive tissue, including the prostate and, relevant here, some aspects of male reproductive physiology [1]. So a drug that lowers DHT systemically can have effects beyond the scalp — which is exactly why the fertility conversation belongs at the start, not after the fact.
Source: [1] Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels (Endocrine Reviews), [2] PROPECIA (finasteride) Prescribing Information — U.S. FDA
What the evidence actually says about semen parameters
This is where forum threads get loud and the data gets quieter. The honest summary: the picture is mixed, and effects — when they appear — are not uniform across men.
The FDA-approved label for finasteride notes that decreased libido, erectile dysfunction, and ejaculation disorders have been reported, and that there have been reports of male infertility and/or poor semen quality that normalized or improved after stopping the drug [2]. That's a signal worth taking seriously, but it's reported data, not a measured rate in every user.
Peer-reviewed work has looked more closely. A study in *Fertility and Sterility* examined men with infertility who were taking finasteride and found that discontinuing it was associated with a meaningful increase in sperm concentration in a subset of men — notably, some men taking even the lower (1 mg) hair-loss dose [3]. The takeaway isn't "finasteride wrecks fertility." It's that in certain men, especially those already dealing with borderline semen parameters, the drug may contribute to a lower sperm count that can improve after stopping [3].
Broader reviews echo the nuance: for most men with normal baseline fertility, standard hair-loss dosing has not been shown to reliably impair the ability to conceive — but individual responses vary, and men with pre-existing subfertility appear to be the more vulnerable group [4]. That variability is the whole reason a baseline matters.
Why a provider asks about family plans first
A responsible independent provider isn't gatekeeping when they ask whether you want children in the next few years. They're trying to sequence the decision correctly.
If kids are years away or off the table, the fertility discussion changes shape. If you're planning to conceive soon, or you already suspect you might have fertility challenges, the calculus is different — and it may be worth establishing where your numbers sit *before* starting anything that acts on DHT. You can't interpret a change you never measured against a baseline you never took.
There's also a separate, non-negotiable safety point built into the finasteride label: it is contraindicated for use in women who are or may become pregnant, and the tablets should not be handled by pregnant women because of the risk to a male fetus [2]. That's about handling and exposure, not the male user's own fertility — but it's part of why this molecule is treated with more care than a cosmetic.
The markers worth a baseline before starting prevention
If conceiving is a real possibility, here are the things that are genuinely useful to have on record first. None of this is a prescription to run every test — it's a menu to discuss with a provider.
A semen analysis. This is the single most direct measure. The World Health Organization publishes reference thresholds for semen parameters — sperm concentration, total count, motility, and morphology — derived from men who fathered children [5]. A baseline analysis gives you and a provider a concrete starting point instead of guesswork.
Hormone context. Testosterone and related markers can help a provider understand your reproductive baseline. This is background, not a target to chase.
A clear read on family history and timeline. Not a lab, but it shapes everything. Your brother going bald by 32 is why you're here; whether you want a kid by 32 is the other half of the equation.
Getting these before starting means that if you ever want to reassess — including stopping to see whether something shifts — you have a real comparison point rather than a vibe.
million/mL · marker = WHO 6th ed. lower reference limit
Source: [5] WHO laboratory manual for the examination and processing of human semen, 6th ed.
What this doesn't mean
This isn't a scare piece, and it isn't advice to avoid DHT-blockers. Millions of men use finasteride, and for many with normal fertility it is not shown to reliably prevent conception [4]. The point is narrower and more useful: fertility is one input among several, it's easier to reason about with a baseline, and the men who benefit most from that baseline are the ones planning to conceive or with existing concerns. This article is educational and is not medical advice; only an independent licensed provider who knows your history can help you decide what's appropriate.
A few practical notes for the research-minded:
- Topical vs. oral matters to the conversation. Some men and providers discuss topical formulations partly because of lower systemic exposure, though the evidence base differs from oral finasteride and reference to any specific product should come from your provider. Where a formulation is compounded: compounded medications are not reviewed or approved by the FDA for safety, effectiveness, or quality. Compounded products are not equivalent to or interchangeable with any FDA-approved brand-name drug. Availability varies by state.
- Reversibility is part of the label discussion. Reports of semen changes that improved after discontinuation are exactly why a baseline is worth having — it lets you and a provider evaluate change over time [2][3].
- Skip the gray market. An unvetted overseas pharmacy can't take a baseline, can't interpret your labs, and can't tell you what's actually in the bottle. A physician-directed path can.
Where Velri fits
Velri is a technology and coordination company — not a medical practice. If you want to explore hair-loss prevention with fertility in mind, Velri can help coordinate the pieces: lab work to establish a baseline, a visit with an independent, licensed provider who reviews your history and goals, and — only if that provider determines it's appropriate and writes a prescription — fulfillment through an independent, licensed pharmacy. A prescription is never guaranteed; that decision belongs entirely to the independent provider. The role Velri plays is making the logistics calm, transparent, and legitimate — so the research-first version of you knows exactly what's happening at each step.
Source: [3] Effect of finasteride on spermatogenesis and pregnancy outcomes (Fertility and Sterility), [5] WHO laboratory manual for the examination and processing of human semen, 6th ed.
